Ontology highlight
ABSTRACT: Background
Immunocompromised travellers (ICTs) face greater infectious and non-infectious travel-associated risks than their immunocompetent counterparts. Increasing travel and emergence of novel immunosuppressants poses great challenges for travel medicine practitioners to confidently provide up-to-date evidence-based risk management advice and pre-travel care for ICTs.Methods
We reviewed the records of ICTs attending the London Hospital for Tropical Diseases (HTD) Travel Clinic between 1st April 2019 and 30th April 2020 with the aim to describe demographic and travel characteristics, type, and severity of immunocompromise, the degree of risk associated with intended travel and evaluate travel advice.Results
Of the 193 ICTs identified, immunocompromise was due to p
SUBMITTER: Beer E
PROVIDER: S-EPMC11017494 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature